The Science to Prevail
We are developing disease-modifying gene therapies for patients with Parkinson’s disease and other neurodegenerative disorders.learn more
verb \ pre·vail \ pre-‘vāl
To prove more powerful than opposing forces. To be victorious. To gain ascendance through strength. To triumph. We are developing disease-modifying gene therapies to prevail against neurodegenerative diseases.
May 24, 2018Prevail Therapeutics Appoints Industry Leader Francois Nader, M.D., to its Board of Directors
March 8, 2018Prevail Therapeutics Announces $75 Million Series A Financing to Advance Gene Therapies for Patients with Parkinson’s and Other Neurodegenerative Diseases
August 9, 2017The Silverstein Foundation, REGENXBIO, and OrbiMed Launch Prevail Therapeutics
Prevail Therapeutics is pioneering the development of gene therapies to halt disease progression in patients with Parkinson’s disease and other neurodegenerative and lysosomal disorders.
Leveraging recent breakthroughs in human genetics and transformative successes of AAV-based gene therapy, our goal is to cure diseases caused by lysosomal dysfunction.learn more